Pay in 4 interest-free payments of $5.55 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
- , , ,
Retatrutide is an investigational triple hormone agonist (GLP-1, GIP, glucagon) showing promising early results for obesity and type 2 diabetes, while tirzepatide is an FDA-approved dual agonist (GLP-1, GIP) available for use today
A nutrient-dense diet not only ensures that your body gets essential nutrients but can also help mitigate potential side effects like nausea or gastrointestinal discomfort that some users experience
Safety and Medical Oversight Matter Because GLP-1 medications and peptide therapies can affect appetite, digestion, blood sugar, hydration, nutrient intake, and other systems, medical oversight is essential
US$ 26.05
US$ 24.55
US$ 20.43
US$ 28.07
US$ 28.94
US$ 25.00
US$ 22.06
US$ 26.32
